OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript

Page 3 of 3

William Febbo: All right, thank you, operator. And thank you, everyone for joining us today. I trust you share in our excitement, and can precede the positive momentum we built throughout the second half of 2023 and now into ’24. As we embark on our financial and operational journey for the year ahead, I’m pleased to say that we are stepping into this new chapter on solid ground. Our reach with healthcare professionals and patients has undergone a remarkable expansion. Thanks to our proprietary AI models. This has allowed us to overcome many of the challenges we faced previously. Today, we proudly offer a comprehensive solution that seamlessly integrates various elements into the powerful agile strategies. These strategies address critical challenges, such as brand awareness and education, affordability, and the recruitment of hard to find patients.

These are the very issues our client’s doctors and patients encounter daily in today’s healthcare landscape, and we are honored to be part of the solution. Our commitment to generally aiding doctors and patients in aligning on care is what truly drives us as a team. Thank you for your time today. And I eagerly anticipate our upcoming discussion on next quarters earnings call. Wishing you all fantastic remainder of the day. Thank you. Operator?

Operator: Thank you, sir. Before we conclude today’s call, I would like to provide the Company’s Safe Harbor statement that includes cautions regarding forward-looking statements made during today’s call. Statements made by management during today’s call may contain forward looking statements with the definition of Section 27A and the Securities Act of 1933 as amended and Section 21E of the Securities Act of 1934 as amended. These forward looking statements should not be used to make investment decisions. The words anticipate, estimate, expect, possible and seeking and similar expressions identify forward-looking statements. They may speak only to the date that such statements are made. Such forward looking statements in this call include statements regarding estimation of total addressable market size, market penetration, revenue growth, gross margin, operating expenses, profitability, cash flow, technology investments, growth opportunities, acquisitions, and upcoming announcements.

They also include management’s expectations for the rest of the year. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events or otherwise. Forward-looking statements are inherently subjects to risk and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth-in contemplated by or underlying these forward looking statements. The risks and uncertainties to which forward-looking statements are subject to include, but are not limited to, the effects of government regulations, competition and other material risk. Risk and uncertainties to which forward looking statements are subject, two could affect business and financial results are included in the company’s annual report on Form 10-K for the quarter ended December 31 2022.

This form is available on the company’s website and on the SEC website at sec.gov. Before we end today’s conference, I would like to remind everyone that this call will be available for replay via webcast, only starting later this evening, running through for a year and a transcript and a link to an audio recording of this conference call will be provided on the Investors section of the company’s website. Thank you for joining us today. This concludes today’s conference call. You may now disconnect your lines.

Follow Optimizerx Corp (NASDAQ:OPRX)

Page 3 of 3